Veterans and government-approved war correspondents who served in areas where Agent Orange (a defoliant containing dioxin) was sprayed during the Vietnam War (from July 18, 1964, to March 23, 1973), and later developed a disease specified in Article 5 of the Act on Assistance to Patients Suffering from Actual or Potential Aftereffects of Defoliants.
Individuals who served as soldiers or civilian employees under the Military Service Act, the Military Personnel Management Act, or the Civilian Personnel Management Act between October 9, 1967, and July 31, 1970, in areas designated by the Ministry of National Defense near the southern boundary of the Demilitarized Zone (DMZ), or who participated in operations involving the spraying of Agent Orange (a defoliant containing dioxin), and later developed a disease specified in Article 5 of the Act on Assistance to Patients Suffering from Actual or Potential Aftereffects of Defoliants.
Individuals who have been registered as eligible under Articles 4 and 7 of the Act on Assistance to Patients Suffering from Actual or Potential Aftereffects of Defoliants, having developed any of the diseases listed in Article 5 (1) of the same Act, and who are children of patients recognized as having died from Agent Orange aftereffects under Article 8, born to mothers who were pregnant during the period of military service in which exposure occurred, and who have developed a disease specified in Article 5 (6) of the Act.
Those who died from diseases specified in Article 5 (1) of the Act on Assistance to Patients Suffering from Actual or Potential Aftereffects of Defoliants,
Those classified as severe, moderate, or mild under the Agent Orange–related aftereffects evaluation are fully covered by the national medical care program, while their family members are not eligible for medical fee reduction benefits.